ZLAB
Zai Lab Limited · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -13.3% ·
aandelenstroom -2.4% ·
netto nieuwe posities -15.4%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 40 | -10 | 13.04M | $247.56M | +1 | −11 |
| Q1 2026 | 51 | -8 | 9.02M | $169.34M | +7 | −15 |
| Q4 2025 | 58 | 0 | 14.32M | $252.66M | +1 | −1 |
| Q3 2025 | 13 | -2 | 15.41M | $522.27M | — | −2 |
| Q2 2025 | 12 | -2 | 15.57M | $544.48M | — | −2 |
| Q1 2025 | 12 | 0 | 13.16M | $475.75M | — | — |
| Q4 2024 | 12 | 0 | 16.81M | $440.22M | +1 | −1 |
| Q3 2024 | 11 | +1 | 20.32M | $490.64M | +1 | — |
| Q2 2024 | 10 | — | 17.23M | $298.54M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 6.08M | +0.7% | $205.97M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 4.70M | -24.1% | $159.34M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 4.70M | -24.1% | $159.34M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 4.70M | -24.1% | $159.34M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 4.70M | -24.1% | $159.34M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Fidelity (FMR) ✦ | 4.70M | -24.1% | $159.34M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Fidelity (FMR) ✦ | 4.70M | -24.1% | $159.34M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 1.72M | +24.8% | $58.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 9 | Wellington Management ✦ | 1.72M | +24.8% | $58.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 10 | Wellington Management ✦ | 1.72M | +24.8% | $58.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 11 | Wellington Management ✦ | 1.72M | +24.8% | $58.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 12 | Wellington Management ✦ | 1.72M | +24.8% | $58.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | Wellington Management ✦ | 1.72M | +24.8% | $58.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | Wellington Management ✦ | 1.72M | +24.8% | $58.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | Wellington Management ✦ | 1.72M | +24.8% | $58.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | Wellington Management ✦ | 1.72M | +24.8% | $58.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 987.04K | +169.5% | $33.45M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 987.04K | +169.5% | $33.45M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 948.67K | +519.9% | $32.15M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | BlackRock ✦ (passief) | 473.56K | +4.0% | $16.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | BlackRock ✦ (passief) | 473.56K | +4.0% | $16.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | BlackRock ✦ (passief) | 473.56K | +4.0% | $16.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | State Street Global Advisors ✦ (passief) | 136.34K | -1.7% | $4.62M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 119.88K | — | $4.06M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 119.88K | — | $4.06M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 119.88K | — | $4.06M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 119.88K | — | $4.06M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 119.88K | — | $4.06M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 119.88K | — | $4.06M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 119.88K | — | $4.06M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Goldman Sachs Group ✦ | 82.18K | — | $2.79M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Marshall Wace ✦ | 61.40K | +151.1% | $2.08M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 33 | Marshall Wace ✦ | 61.40K | +151.1% | $2.08M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 34 | Geode Capital Management ✦ (passief) | 50.58K | -10.5% | $1.71M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 35 | D. E. Shaw & Co. ✦ | 34.29K | -87.7% | $1.16M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 45 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 46 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 47 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 48 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 49 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Point72 Asset Management | $8.83M | was 0.0% |
| Renaissance Technologies | $8.14M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 97 houders, 28.24M aandelen, $515.77M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 260 aand · $7,020
Director · 8.51K aand · $212,650
Officer · 619 aand · $15,475
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie